Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/32212
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Barraclough, Allison | - |
dc.contributor.author | England, James T | - |
dc.contributor.author | Villa, Diego | - |
dc.contributor.author | Wight, Joel C | - |
dc.contributor.author | Hapgood, Greg | - |
dc.contributor.author | Conn, Jason | - |
dc.contributor.author | Doo, Nicole Wong | - |
dc.contributor.author | Li, Eric Wenlong | - |
dc.contributor.author | Gilbertson, Michael | - |
dc.contributor.author | Shaw, Briony | - |
dc.contributor.author | Bishton, Mark J | - |
dc.contributor.author | Saeed, Malik | - |
dc.contributor.author | Ratnasingam, Sumita | - |
dc.contributor.author | Abeyakoon, Chathuri | - |
dc.contributor.author | Chong, Geoff | - |
dc.contributor.author | Wai, Shin Hnin | - |
dc.contributor.author | Ku, Matthew | - |
dc.contributor.author | Lee, Hui-Peng | - |
dc.contributor.author | Fleming, Kathryn | - |
dc.contributor.author | Tam, Constantine | - |
dc.contributor.author | Douglas, Genevieve | - |
dc.contributor.author | Cheah, Chan Y | - |
dc.contributor.author | Ng, Zi Yun | - |
dc.contributor.author | Rolfe, Tukten | - |
dc.contributor.author | Mills, Anthony K | - |
dc.contributor.author | Hamad, Nada | - |
dc.contributor.author | Cashman, Helen | - |
dc.contributor.author | Gleeson, Mary | - |
dc.contributor.author | Narayana, Manjunath | - |
dc.contributor.author | Hawkes, Eliza A | - |
dc.date | 2023 | - |
dc.date.accessioned | 2023-03-01T03:55:57Z | - |
dc.date.available | 2023-03-01T03:55:57Z | - |
dc.date.issued | 2023-09-01 | - |
dc.identifier.citation | Haematologica 2023; 108(9) | en_US |
dc.identifier.issn | 1592-8721 | - |
dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/32212 | - |
dc.description.abstract | Grade (G) 3B follicular lymphoma (FL) is a rare FL subtype which exists on a histological continuum between 'low-grade' (Grade 1, 2 and 3A FL) and diffuse large B-cell lymphoma (DLBCL) appearing to share features with each. Clinical characteristics and outcomes are poorly understood due to lack of adequate representation in prospective trials and large-scale analyses. We analyzed 157 G3BFL cases from 18 international centers, and two comparator groups; G3AFL (n=302) and DLBCL (n=548). Composite histology with DLBCL or low-grade FL occurred in approximately half of G3BFL cases. With median 5 years follow-up, G3BFL overall (OS; P. | en_US |
dc.language.iso | eng | - |
dc.subject | follicular lymphoma | en_US |
dc.title | Outcomes in grade 3B follicular lymphoma: an international study led by the Australasian Lymphoma Alliance. | en_US |
dc.type | Journal Article | en_US |
dc.identifier.journaltitle | Haematologica | en_US |
dc.identifier.affiliation | Fiona Stanley Hospital, Department of Haematology, Perth, Australia; University of Melbourne, Melbourne. | en_US |
dc.identifier.affiliation | University of British Columbia and BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada; Princess Margaret Cancer Centre, Toronto. | en_US |
dc.identifier.affiliation | University of British Columbia and BC Cancer Centre for Lymphoid Cancer, Vancouver. | en_US |
dc.identifier.affiliation | University of Melbourne, Melbourne, Australia; Townsville University Hospital, Department of Haematology, Townsville. | en_US |
dc.identifier.affiliation | Princess Alexandra Hospital, Department of Haematology, Brisbane. | en_US |
dc.identifier.affiliation | Concord Clinical School, University of Sydney, Sydney. | en_US |
dc.identifier.affiliation | Monash Health, Department of Haematology, Melbourne, Australia; School of Clinical Sciences, Monash University, Melbourne. | en_US |
dc.identifier.affiliation | Monash Health, Department of Haematology, Melbourne. | en_US |
dc.identifier.affiliation | Nottingham City Hospital, Department of Haematology, Nottingham. | en_US |
dc.identifier.affiliation | University Hospital Geelong, Department of Haematology, Geelong. | en_US |
dc.identifier.affiliation | University of Melbourne, Melbourne, Australia; Ballarat Regional Integrated Cancer Centre, Ballarat Health Services, Melbourne, Australia; Department of Medical Oncology and Haematology, Olivia Newton-John Cancer Research and Wellness Centre, Austin Health, Melbourne. | en_US |
dc.identifier.affiliation | University of Melbourne, Melbourne, Australia; St Vincent's Hospital Melbourne, Department of Haematology, Melbourne. | en_US |
dc.identifier.affiliation | Flinders Medical Centre, Department of Haematology, Adelaide. | en_US |
dc.identifier.affiliation | Flinders Medical Centre, Department of Haematology, Adelaide. | en_US |
dc.identifier.affiliation | University of Melbourne, Melbourne, Australia; Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Department of Haematology, Melbourne. | en_US |
dc.identifier.affiliation | Department of Medical Oncology and Haematology, Olivia Newton-John Cancer Research and Wellness Centre, Austin Health, Melbourne. | en_US |
dc.identifier.affiliation | Sir Charles Gairdner Hospital, Department of Haematology, Perth, Australia; University of Western Australia, Medical School, Perth. | en_US |
dc.identifier.affiliation | Sir Charles Gairdner Hospital, Department of Haematology, Perth. | en_US |
dc.identifier.affiliation | Greenslopes Private Hospital, Brisbane. | en_US |
dc.identifier.affiliation | St Vincent's Hospital Sydney, Department of Haematology, Sydney, Australia; School of Clinical Medicine, University of New South Wales, Sydney, Australia; School of Medicine, University of Notre Dame, Sydney. | en_US |
dc.identifier.affiliation | St Vincent's Hospital Sydney, Department of Haematology, Sydney. | en_US |
dc.identifier.affiliation | Guy's and St. Thomas' NHS Foundation Trust, Department of Haematology, London. | en_US |
dc.identifier.affiliation | Sunshine Coast University Hospital, Department of Haematology, Birtinya. | en_US |
dc.identifier.affiliation | Medical Oncology | en_US |
dc.identifier.affiliation | Olivia Newton-John Cancer Research Institute | en_US |
dc.identifier.affiliation | Clinical Haematology | en_US |
dc.identifier.doi | 10.3324/haematol.2022.281375 | en_US |
dc.type.content | Text | en_US |
dc.identifier.pubmedid | 36815381 | - |
local.name.researcher | Barraclough, Allison | - |
item.openairetype | Journal Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
crisitem.author.dept | Clinical Haematology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
crisitem.author.dept | Clinical Haematology | - |
crisitem.author.dept | Clinical Haematology | - |
crisitem.author.dept | Olivia Newton-John Cancer Wellness and Research Centre | - |
crisitem.author.dept | Olivia Newton-John Cancer Research Institute | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.